- Founded
- 2006
- Business Model
- B2C
- Website
- medmark.com
- Last Round
- Growth EquityAug 2026
- Rounds
- 1
About
MedMark Treatment Centers provides outpatient, medication-assisted treatment and counseling to help people recover from opioid use disorder across the United States. Since 2006, the company has helped thousands of people access effective opioid use disorder treatment and rebuild their lives. What began with three programs in Northern California has evolved into a nationwide network of over 50 treatment centers, delivering evidence-based, compassionate care that fits patients' lives and supports long-term wellness.
Summary
Medmark is a Drug Discovery company, founded in 2006. Its most recent funding was a Growth Equity round in Aug 2026. Investors include Phoenix Holdings.
Funding History
Aug 2026
Investors
Similar Companies
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/medmark"><img src="https://indexed.vc/api/badge/company/medmark" alt="Medmark on Indexed.vc" width="260" height="76" /></a>